|
|
|
|
TABLE OF CONTENTS
_____________________ |
|
|
|
|
|
|
|
SHM >> references
|
|
|
|
| 1. |
Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress
in United States women. Obstet Gynecol 2008;112:970-978. |
| 2. |
West SL, D’Aloisio AA, Agans RP, et al. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern
Med 2008;168:1441-1449. |
| 3. |
Basson R. Is it time to move on from “hypoactive sexual desire disorder”? Menopause 2010;17:1097-1098. |
| 4. |
Rosen RC, Shifren JL, Monz BU, et al. Correlates of sexually related personal distress
in women with low sexual desire. J Sex Med 2009;6:1549-1560. |
| 5. |
Lindau ST, Schumm LP, Laumann EO, Levinson W, O’Muircheartaigh CA, Waite LJ.
A study of sexuality and health among older adults in the United States. N Engl J Med
2007;357:762-774. |
| 6. |
Oskay UY, Beji NK, Yalcin O. A study on urogenital complaints of postmenopausal
women aged 50 and over. Acta Obstet Gynecol Scand 2005;84:72-78. |
| 7. |
Ballinger SE. Psychosocial stress and symptoms of menopause: a comparative study
of menopause clinic patients and non-patients. Maturitas 1985;7:315-327. |
| 8. |
Versi E, Harvey MA, Cardozo L, et al. Urogenital prolapse and atrophy at menopause:
a prevalence study. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:107-110. |
| 9. |
Saigal CS, Wessells H, Pace J, et al. Predictors and prevalence of erectile dysfunction
in a racially diverse population. Arch Intern Med 2006;166:207-212. |
| 10. |
Schick V, Herbenick D, Reece M, et al. Sexual behaviors, condom use, and sexual
health of Americans over 50: implications for sexual health promotion for older adults.
J Sex Med 2010;7(suppl 5):315-329. |
| 11. |
Shifren JL, Johannes CB, Monz BU, Russo PA, Bennett L, Rosen R. Help-seeking
behavior of women with self-reported distressing sexual problems. J Women’s Health
2009;18:461-468. |
| 12. |
Baker FC, Wolfson AR, Lee KA. Association of sociodemographic, lifestyle, and
health factors with sleep quality and daytime sleepiness in women: findings from
the 2007 National Sleep Foundation “Sleep in America Poll.” J Womens Health
(Larchmt) 2009;18:841-849. |
| 13. |
Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released
from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet
Gynecol Reprod Biol 1997;71:73-80.
|
| 14. |
Simunic V, Banovic I, Ciglar S, et al. Local estrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obstet 2003;82:187-197. |
| 15. |
Eriksen PS, Rasmussen H. Low-dose 17 beta-estradiol vaginal tablets in the treatment
of atrophic vaginitis: a double-blind placebo controlled study. Eur J Obstet Gynecol
Reprod Biol 1992;44:137-144.
|
| 16. |
Casper F, Petri E. Local treatment of urogenital atrophy with an estradiol-releasing
vaginal ring: a comparative and a placebo-controlled multicenter study. Int Urogynecol J Pelvic Floor Dysfunct 1999;10:171-176. |
| 17. |
Lose G, Englev E. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries
in the treatment of bothersome lower urinary tract symptoms. Br J Obstet Gynaecol 2000;107:1029-1034. |
| 18. |
Labrie F, Archer D, Bouchard C, et al. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause
2009;16:923-931. |
| 19. |
Nurnberg HG, Hensley PL, Heiman JR, et al. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA 2008; 300:395-404. |
|
|
|
|
|
|
|